Peripheral Neuropathy, Chemotherapy-induced

1

Review clinical trials related to Peripheral Neuropathy, Chemotherapy-induced. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Study on the Efficacy and Safety of Mecobalamin in Preventing Taxane-related Peripheral Neuropathy

Some patients receiving taxane-based chemotherapy experience numbness, tingling, or pain in their hands and feet, known as chemotherapy-induced peripheral neuropathy (CIPN). This study aims to find out whether oral mecobalamin can prevent or reduce CIPN. Participants will be assigned to take mecobalamin or to receive no routine mecobalamin prevention during chemotherapy, and outcomes will be compared between groups.

Participants needed: 326
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Qinghai Red Cross HospitalUpdated: Apr 30, 2026Locations: 4
Eligibility criteria

Histologically or cytologically confirmed solid tumors, including but not limite... [+6]

Severe impairment of major organ function such that the participant cannot toler... [+6]